Načítá se...
Engineering virus-like particles as vaccine platforms
Virus-like particles (VLPs) have been utilized as vaccine platforms to increase the immunogenicity of heterologous antigens. A variety of diverse VLP types can serve as vaccine platforms, and research has focused on engineering VLPs to improve their efficacy as vaccines, enhance their stability, and...
Uloženo v:
| Vydáno v: | Curr Opin Virol |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4983494/ https://ncbi.nlm.nih.gov/pubmed/27039982 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.coviro.2016.03.001 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|